Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
A Preliminary Direct Comparison of the Inflammatory Reduction and Growth Factor Production Capabilities of Three Commercially Available Wound Products: Collagen Sheet, Manuka Honey Sheet, and a Novel Bioengineered Collagen Derivative + Manuka Honey + Hydroxyapatite Sheet. | Int J Mol Sci | 2022 | 36142583 | PubTator, text mining | PubMed |
| The Multi-Omic Landscape of Primary Breast Tumors and Their Metastases: Expanding the Efficacy of Actionable Therapeutic Targets. | Genes (Basel) | 2022 | 36140723 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition by Synergy between Transforming Growth Factor-β and Growth Factors in Cancer Progression. | Diagnostics (Basel) | 2022 | 36140527 | PubTator, text mining | PubMed |
| Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein-Barr Virus Infection. | Curr Oncol | 2022 | 36135044 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection of human pluripotent stem cell-derived liver organoids reveals potential mechanisms of liver pathology. | iScience | 2022 | 36128218 | PubTator, text mining | PubMed |
| Phenotypic spectrum of FGF10-related disorders: a systematic review. | PeerJ | 2022 | 36124135 | PubTator, text mining | PubMed |
| MicroRNA-106b-5p (miR-106b-5p) suppresses the proliferation and metastasis of cervical cancer cells via down-regulating fibroblast growth factor 4 (FGF4) expression. | Cytotechnology | 2022 | 36110154 | PubTator, text mining | PubMed |
| FGF/FGFR-related lncRNAs based classification predicts prognosis and guides therapy in gastric cancer. | Front Genet | 2022 | 36105076 | PubTator, text mining | PubMed |
| Different transcriptional profiles of human embryonic stem cells grown in a feeder-free culture system and on human foreskin fibroblast feeder layers. | Aging (Albany NY) | 2022 | 36103219 | PubTator, text mining | PubMed |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. | Br J Cancer | 2022 | 36088510 | PubTator, text mining | PubMed |
| Genetic Parameter Estimation and Genome-Wide Association Analysis of Social Genetic Effects on Average Daily Gain in Purebreds and Crossbreds. | Animals (Basel) | 2022 | 36078021 | PubTator, text mining | PubMed |
| Multiple Cell Cultures for MRI Analysis. | Int J Mol Sci | 2022 | 36077507 | PubTator, text mining | PubMed |
| Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process. | Int J Mol Sci | 2022 | 36077465 | PubTator, text mining | PubMed |
| Tumor suppressors inhibit reprogramming of African spiny mouse ( Acomys) fibroblasts to induced pluripotent stem cells. | Wellcome Open Res | 2022 | 36060301 | PubTator, text mining | PubMed |
| Mechanism of paracrine communications between hepatic progenitor cells and endothelial cells. | Cell Signal | 2022 | 36055565 | PubTator, text mining | PubMed |
| What's New in Topicals for Atopic Dermatitis? | Am J Clin Dermatol | 2022 | 36048410 | PubTator, text mining | PubMed |
| Stable iPSC-derived NKX2-1+ lung bud tip progenitor organoids give rise to airway and alveolar cell types. | Development | 2022 | 36039869 | PubTator, text mining | PubMed |
| Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas. | Genome Med | 2022 | 36038884 | PubTator, text mining | PubMed |
| Regulation of Embryonic Stem Cell Self-Renewal. | Life (Basel) | 2022 | 36013330 | PubTator, text mining | PubMed |
| Internal Ribosome Entry Site (IRES)-Mediated Translation and Its Potential for Novel mRNA-Based Therapy Development. | Biomedicines | 2022 | 36009412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=27